Colgate-Palmolive (NYSE:CL) Shares Sold by Country Club Bank

Country Club Bank cut its holdings in Colgate-Palmolive (NYSE:CL) by 7.9% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 9,301 shares of the company’s stock after selling 800 shares during the period. Country Club Bank’s holdings in Colgate-Palmolive were worth $913,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also modified their holdings of the company. Federated Hermes Inc. boosted its holdings in shares of Colgate-Palmolive by 560.2% in the 4th quarter. Federated Hermes Inc. now owns 288,537 shares of the company’s stock valued at $22,999,000 after buying an additional 244,834 shares during the period. Mitchell Sinkler & Starr PA boosted its stake in Colgate-Palmolive by 92.6% during the 4th quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock valued at $3,659,000 after purchasing an additional 22,073 shares during the period. Xponance Inc. boosted its stake in Colgate-Palmolive by 7.9% during the 4th quarter. Xponance Inc. now owns 182,775 shares of the company’s stock valued at $14,569,000 after purchasing an additional 13,342 shares during the period. Stonehage Fleming Financial Services Holdings Ltd boosted its stake in Colgate-Palmolive by 57.1% during the 4th quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock valued at $30,594,000 after purchasing an additional 139,429 shares during the period. Finally, D L Carlson Investment Group Inc. acquired a new position in Colgate-Palmolive during the 4th quarter valued at about $3,269,000. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction dated Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, insider Panagiotis Tsourapas sold 14,794 shares of Colgate-Palmolive stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total value of $1,522,894.36. Following the sale, the insider now directly owns 5,146 shares in the company, valued at $529,729.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Sally Massey sold 15,850 shares of the firm’s stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the transaction, the insider now directly owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The disclosure for this sale can be found here. Insiders sold 41,177 shares of company stock worth $4,245,835 in the last quarter. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Price Performance

Shares of CL stock traded down $0.74 during mid-day trading on Thursday, reaching $101.44. The company’s stock had a trading volume of 3,303,317 shares, compared to its average volume of 4,414,898. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $104.15. The company has a market cap of $83.23 billion, a P/E ratio of 32.32, a PEG ratio of 3.54 and a beta of 0.39. The company has a debt-to-equity ratio of 16.90, a quick ratio of 0.28 and a current ratio of 1.06. The firm’s 50-day moving average is $97.98 and its two-hundred day moving average is $92.00.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings data on Friday, July 26th. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The company had revenue of $5.06 billion during the quarter, compared to analysts’ expectations of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s revenue was up 4.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.77 EPS. On average, research analysts predict that Colgate-Palmolive will post 3.57 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Investors of record on Friday, July 19th will be given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.97%. The ex-dividend date of this dividend is Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research note on Friday, July 26th. Wells Fargo & Company upped their price target on shares of Colgate-Palmolive from $92.00 to $97.00 and gave the stock an “equal weight” rating in a research note on Wednesday, July 10th. Sanford C. Bernstein boosted their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a report on Tuesday, July 30th. Barclays boosted their price target on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a report on Monday, July 29th. Finally, Citigroup boosted their target price on shares of Colgate-Palmolive from $103.00 to $112.00 and gave the stock a “buy” rating in a research report on Wednesday, July 10th. Eight research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat.com, Colgate-Palmolive has an average rating of “Moderate Buy” and an average price target of $101.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.